There is now general agreement that neurokinin B (NKB) acts via NK3R to stimulate secretion of 26 gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) in a number of species, including 27 rats, mice, sheep, and humans. However the roles of two other tachykinins, substance P (SP) and 28 neurokinin A (NKA), which act primarily via NK1R and NK2R respectively, are less clear. In rodents, 29 these signaling pathways can stimulate LH release and substitute for NKB signaling; in humans, SP is 30 colocalized with kisspeptin and NKB in the mediobasal hypothalamus. In this study, we examined the 31 possible role of these tachykinins in control of the reproductive axis in sheep. Immunocytochemistry was 32 used to describe the expression of SP and NK1R in the ovine diencephalon and determine if these 33 proteins are colocalized in kisspeptin or GnRH neurons. SP-containing neurons were largely confined to 34 the arcuate nucleus (ARC), but NK1R-immunoreactivity was more widespread, with relatively high 35 expression in the lateral preoptic area, the ventromedial nucleus, and the ARC. However, there was very 36 low coexpression of SP or NK1R in kisspeptin cells and none in GnRH neurons. We next determined the 37 minimal effective dose of these three tachykinins that would stimulate LH secretion when administered 38 into the third cerebral ventricle of ovary-intact anestrous sheep. A much lower dose of NKB (0.2 nmoles) 39 than of NKA (2 nmoles) or SP (10 nmoles) consistently stimulated LH secretion. Moreover, the relative 40 potency of these three neuropeptides parallels the relative selectively of NK3R. Based on these 41 anatomical and pharmacological data, we conclude that NKB-NK3R signaling is the primary pathway for 42
Introduction 44
Recent studies (1-3) on the reproductive effects of mutations in the TAC3 gene that encodes neurokinin B 45 (NKB) or in the gene (TACR3) that encodes its receptor (NK3R) have focused the attention of 46 reproductive neuroendocrinologists on the possible roles of tachykinins in control of gonadotropin-47 releasing hormone (GnRH), luteinizing hormone (LH), and follicle stimulating hormone (FSH) secretion. 48
In addition to NKB, two other tachykinins have been implicated in the control of reproduction: substance 49 P (SP) and neurokinin A (NKA). These peptides are both encoded by the same gene (TAC1) and act via 50 NK1R and NK2R, respectively (4, 5) . At this time there are no reports that mutations in TAC1 or the genes 51 for NK1R or NK2R produce reproductive deficits in humans, but other approaches have implicated these 52 two tachykinins in the control of GnRH secretion (4). 53
A stimulatory role for NKB in control of GnRH in humans was first proposed in 1991 based on 54 the increase in NKB expression in post-menopausal women within the infundibular nucleus (6), which is 55 analogous to the arcuate nucleus (ARC) in other species. These cells also contain kisspeptin and 56 dynorphin and thus are now known as KNDy neurons (7, 8) . More recently, work across a number of 57 species, spurred on by the human genetic studies, has produced considerable evidence in support of this 58 hypothesis. In most studies NKB, or more often senktide (an NK3R agonist), stimulated LH secretion via 59
GnRH in gonadally-intact animals or when LH secretion was suppressed with exogenous steroids (9-13). 60
Conversely, antagonists to NK3R inhibited LH secretion in ovariectomized (OVX) sheep (14-16), 61 castrated monkeys (16), and normal men and women (17). Interestingly most, but not all (18), studies 62 indicate that these stimulatory effects are mediated by kisspeptin released from KNDy neurons. Thus, 63
KNDy neurons contain NK3R (19-21) and NKB, or senktide, increased their activity, based on Fos 64 expression, in vivo (22, 23) or electrical activity in hypothalamic slices (13, 24, 25) . Moreover, these 65 agonists did not stimulate LH secretion in the absence of Kiss1r in mice (26), in the presence of a Kiss1r 66 antagonist in rats (27), or when Kiss1r was down-regulated in primates (28) . In contrast to these 67 stimulatory effects of senktide when endogenous GnRH secretion is low, this NK3R agonist inhibits LH 68 secretion in OVX rats (29, 30) and mice (21), probably by stimulating dynorphin release from KNDy 69
neurons (31). 70
There are fewer studies on the roles of SP and NKA, but recent work in rodents indicates that 71 these tachykinins can have effects similar to NKB on LH and FSH secretion. Thus NKA and SP 72 increased the firing rate of murine KNDy neurons in vitro (25) and specific NK1R or NK2R agonists 73 increased LH and FSH secretion in rats (32) and mice (12), with the latter effects being dependent on 74
Kiss1r signaling (12) . Similarly knockout of Tac1 delayed puberty and decreased ovulation rate and the 75 number of pups/litter in mice (33). Finally, there may well be some redundancy among the three 76 tachykinin signaling pathways in rodents because blockade of all three receptors is required to inhibit LH 77 secretion in OVX rats (34) . Similarly, stimulatory effects of NKB on the electrical activity of murine 78
KNDy neurons in vitro is not blocked by each selective NKR antagonist alone, but is blocked by a 79 cocktail of all three receptor antagonists (25) . 80
The limited work on SP and NKA in other species has largely focused on the former. In humans, 81 infusion of SP stimulated LH, but not FSH, secretion (35) and SP expression in the infundibular nucleus 82 is higher in post-menopausal women than in pre-menopausal women (6) and higher than expression in 83 both young and aged men (36). Immunocytochemical (ICC) studies using tissue from post-menopausal 84 women indicated that 25% of NKB-containing and 31% of kisspeptin-containing cell bodies also 85 expressed SP (36) and similar colocalization was observed in close contacts with GnRH axonal fibers in 86 the median eminence (37). On the other hand, in male rhesus monkeys, SP was not found in kisspeptin-87 containing neurons and iv injection of SP failed to stimulate LH secretion (38). Moreover, an NK1R 88 antagonist increased both LH and FSH concentrations during the descending phase of an estrogen-89 induced surge in cynomologus monkeys, suggesting a possible inhibitory effect of SP (39). 90
Studies in sheep have provided important information on the expression and actions of NKB 91 (8, 9, (14) (15) (16) 19, 40) , but there is no information in this species on the role of other tachykinins in control of 92
GnRH secretion. This work addressed this gap in our knowledge by: 1) describing the expression of SP 93 and NK1R in the ovine preoptic area (POA) and hypothalamus, 2) determining if either was colocalized 94 with kisspeptin-or GnRH-containing neurons and the effect of estradiol (E 2 ) on their expression, and 3) 95 comparing the minimal dose of NKB, SP, and NKA required to stimulate LH secretion in ovary-intact 96 anestrous ewes. We chose to monitor LH concentrations because they provide a reliable index of episodic 97
GnRH secretion. In contrast, patterns of FSH do not reflect endogenous GnRH pulses (41) and FSH 98 elevations are not seen in response to exogenous GnRH injections that produce LH pulses (41, 42) . 99 100
Materials & Methods 101
Animals 102
Adult (4-8 years of age) multiparous blackface ewes of predominantly Suffolk breeding were maintained 103 in an open barn and moved indoors 3-7 days prior to surgeries. Ewes were fed a pelleted alfalfa diet to 104 maintain weight (65-85 kg) and provided free access to water and supplemental minerals. Lighting was 105 adjusted bimonthly to mimic the duration of natural day light. All experiments used anestrous ewes and 106
were performed between the middle of April and the end of July. 107
Surgical and blood collection procedures 108
All surgeries were performed under aseptic conditions using 2-4 % isofluorane in oxygen for anesthesia. 109
For OVX, ovaries were exposed via mid-ventral laporatomy, the blood supply ligated, and the ovaries 110 removed. Any blood clots adhering to the uterus or oviducts were then removed with sterile saline, these 111 organs returned to the abdomen, and the peritoneum and skin were sutured closed. For 112 intracerebroventricular (icv) administration of tachykinins, an 18-gauge stainless steel cannula was 113 stereotaxically placed into the third ventricle, cemented in place with dental acrylic, protected with a 114 plastic cap, and the hub plugged to prevent CSF backflow (43). All ewes were treated with 115 dexamethasone and penicillin from 1 day before to 5 days after surgery, and with analgesic (125 mg; 116 Banamine, Phoenix Pharmaceutical, St. Joseph, MO) at the time of anesthesia induction and for 5 days 117 after surgery. Animals were allowed to recover from surgical procedures for at least 7 days before any 118 experimental treatments. Jugular blood samples (3-4 mL) were taken by venipuncture, placed in 119 heparinized tubes, and plasma collected and stored at -20 C until assayed for LH. All procedures were 120 approved by the West Virginia University Animal Care and Use Committee and conducted in accordance 121 with NIH guidelines on the care and use of animals in research. 122
Tissue collection 123
Paraformaldhyde-fixed tissue was collected for immunocytochemistry and histological determination of 124 treatment sites. Ewes were injected with two doses of 20,000 units of heparin (10 mins apart) and then 125 euthanized with an overdose (8-12 mL, iv) of sodium pentobarbital (Euthasol; Patterson Veterinary, 126
Devens, MA). The head was removed when the animal had stopped breathing and perfused via the 127 internal carotids with 6 L of 4 % paraformaldehyde in 0.1 M phosphate buffer containing 0.1 % NaNO 3 . 128
Tissue blocks containing hypothalamus and preoptic area (POA) were removed and stored in fixative at 4 129 °C overnight and then in 20% sucrose. After sucrose infiltration, 45-μm-thick frozen coronal sections 130 were cut using a freezing microtome. For ICC, 6 parallel series of sections (270 μm 
NK1R expression. 134
All immunohistochemical studies were conducted on tissue collected from a cohort of anestrous ewes that 135 did not undergo intracranial surgeries. Anestrous animals were OVX, as described above, and a 3 cm 136 long E 2 -containing Silastic implant was inserted subcutaneously (s.c.) (OVX+ E 2 ; n=5) or sham inserted 137 (OVX; n=5) at the end of the surgical procedure. Animals were perfused, as described above, and tissue 138 was collected 10 days later. 139
Experiment 3. LH dose-response to NKB in ovary-intact anestrous ewes 140
Chronic cannulae were placed in the third ventricle of ovary-intact anestrous ewes (n=4) in the middle of 141
April. This experiment was done in ovary-intact ewes to avoid multiple survival surgeries. A stock 142 solution of NKB (Tocris Bioscience, Ellisville MO) was prepared the day before the first treatments by 143 dissolving 0.6 mg NKB in 0.375 mL of 0.1 N NaOH (1 nmole/µL) (44). Aliquots of this stock solution 144
were stored at -20 C, and then thawed and diluted with sterile artificial CSF (aCSF) (45) on the day of 145 treatments to produce concentrations ranging from 0.05 to 0.5 nmoles/100 µL. Because the stock was 146 diluted 1:200 to prepare the highest dose of NKB, we used 0.1 N NaOH diluted 1:200 with aCSF as 147 vehicle for the 0 nmole treatment. This study was originally designed to determine a dose of NKB that 148 would reliably induce a physiological LH pulse for analysis of receptor turnover (46), so LH was only 149 monitored for 2 hr after injection. Starting 9-10 days after surgery, blood samples were collected every 150 12 min from 24 min before to 2 hrs after icv injection (100 µL) of 0 (100 µL of vehicle), 0.05 nmoles 151 NKB, 0.1 nmoles NKB, 0.2 nmoles NKB, or 0.5 nmoles NKB. This protocol was then repeated four 152 more times, with 3-5 days between treatments so that all animals received all five treatments in a random 153 order. Tissue was collected after the last treatment and location of cannulae in the third ventricle 154 confirmed. In a follow-up experiment the response to 0.2 nmoles of NKB was assessed in a separate set of 155 five ovary-intact anestrous ewes using this protocol. 156
Experiment 4. What doses of NKA and SP are needed to stimulate LH secretion in ovary-intact anestrous 157

ewes? 158
Chronic third ventricle cannulae were implanted in 5 ovary-intact ewes in early June. This experiment 159 was designed to test two doses of NKA and SP. Based on the results of Exp. 3, and the relative potency 160 of NKB, SP, and NKA in stimulating electrical activity of KNDy neurons in mice (25), we first compared 161 the effects of 2 nmoles of NKA and SP with vehicle controls. We then planned to either increase or 162 decrease the dose of these tachykinins based on the effects at this dose, which resulted in administration 163 of 0.5 nmoles NKA and 10 nmoles of SP to these ewes in the second part of this experiment. Stock 164 solutions of 0.5 nmoles tachykinin/µL of aCSF were prepared before the first treatment, aliquots frozen, 165 and diluted with aCSF to the appropriate concentration on the morning of all treatments. Starting two 166 weeks after neurosurgery, ewes received icv injections of either aCSF, 2 nmoles NKA, or 2 nmoles SP in 167 random order with 3-4 days between treatments. LH concentrations were measured in plasma samples 168 collected from 36 min before to 4 hr after injections. One week after the last set of injections, samples 169 were again collected for 36 min before to 4 hr after injection of either 0.5 nmoles NKA or 10 nmoles SP, 170 and this treatment repeated with a cross-over design so that each ewe received both treatments. At the end 171 of the experiment, tissue was collected to confirm that cannulae were in the third ventricle. 172
Immunohistochemistry 173
Free floating, double-label, immunofluorescence histochemistry was performed in order to determine the 174 distribution of SP and NK1R, and investigate their potential colocalization with kisspeptin and/or GnRH 175 in the sheep POA and hypothalamus. Furthermore, we processed tissue sections from OVX and OVX+ 176 E 2 ewes to determine whether E 2 regulates protein expression of SP or NK1R. Hence, a series of every 177 sixth section, extending from the level of the optic chiasma to the mammillary bodies, was processed for 178 each of the following four combinations: a) SP and kisspeptin, b) NK1R and kisspeptin, c) SP and GnRH, 179 or d) NK1R and GnRH using a modified protocol previously described and routinely used in our 180 laboratory (8). Briefly, all steps were performed at room temperature and with gentle agitation, and tissue 181 sections were washed with 0.1M phosphate buffered (pH 7.35) saline (PBS) between each step. 182
Antibodies were diluted in PBS + , a solution consisting of 0.1M PBS, 0.4% Triton X-100 (Sigma-Aldrich, 183
St. Louis MO ) and 4% normal goat serum (Jackson ImmunoResearch Labortories, West Grove, PA). 184
Before the application of the first primary antibody, sections were treated with 1% hydrogen peroxide 185 (H 2 O 2 ) for 10 min followed by PBS + for 1 hr to prevent nonspecific background labeling. Tissue sections 186
were then incubated sequentially with: 1) guinea pig anti-SP (1:4,000, Abcam, Cambridge, MA; Table 1 ) 187 or rabbit anti-NK1R (1:10,000, Millipore, Billerica, MA; Table 1) (1:100, Invitrogen, Carlsbad, CA) for 30 min. Tissue was protected from light from this step forward. 193
Next, sections were incubated with rabbit anti-kisspeptin (1:1,000, Millipore; Table 1) Williston, VT) to superimpose the two images and determine colocalization. For each section, the total 213 number of single and double labeled (Kiss+SP, Kiss+NK1R, GnRH+SP, GnRH+NK1R) cells were 214 counted by flipping through the green and red channels. Counts were averaged per ewe, per brain area. 215
Percentages of the total number of kisspeptin-or GnRH-ir cells containing SP or NK1R as well as the 216 percentages of SP-or NK1R-ir cells containing kisspeptin or GnRH were calculated for each section, and 217 averaged per ewe, per brain area. 218
In addition to cell counts, the effects of E 2 on SP fiber density in the ARC was examined because SP cell 219 bodies where observed infrequently. A midlevel section of the ARC was selected for imaging and 220 quantification of the density of SP-containing fibers. Fibers were visualized and photographed with a 20X 221 objective lens (Microfire A/R). Data from these images were then analyzed using Image J software (NIH, 222 Bethesda, MD). A standardized threshold was applied to all images and the proportion of immunolabeling 223 above threshold was quantified for each section. Therefore the data represent the proportional area 224 occupied by labeled fibers, not the specific number of fibers. Two images per animal were analyzed and 225 these data averaged to obtain values for that animal. Group data are expressed as the mean ± SEM. 226
227
LH Assay 228
Ovine LH concentrations in plasma (200 µL) were measured in duplicate with a RIA using reagents 229 provided by the National Hormone and Peptide Program as previously described (49). The sensitivity of 230 the assay averaged 0.04 ng/tube (NIH S24) and the intra-and interassay coefficients of variation were 231 5.9% and 9.8%, respectively. 232
233
Statistical analyses 234
For Exp. 2, the number of single-labeled kisspeptin, GnRH, or NKR1 perikarya were compared between 235 OVX and OVX+ E 2 groups using a two-way ANOVA (region and hormone treatment as main factors) 236
and Holm-Sidak posthoc test, whenever appropriate. Densities of SP fibers in the ARC were compared 237 between OVX and OVX+ E 2 groups by t-test. For analysis of the effects of tachykinins on LH secretion 238 (Exp. 3 and 4), an increase in LH concentrations following injection of a tachykinin was considered to be 239 a response if it occurred within 2 samples of the injection and peak LH concentrations were two SD above 240 the preinjection value, based on assay variability. For Exp. 3, mean LH concentrations before and for 0-2 241 hrs after injection were compared by two-way ANOVA with repeated measures (time and dose of NKB 242 were the main factors), and the Holm-Sidak test was used for comparisons within treatments. LH pulse 243 amplitudes and frequencies after injection were determined using established criteria for LH pulses (50). 244
Amplitudes were analyzed by one-way ANOVA with repeated measures and pulse frequencies by the 245 non-parametric Kruskal-Wallis one-way ANOVA on Ranks. For Exp. 4, mean LH concentrations before, 246 for 0-2 hrs after, and for 2-4 hrs after injection were analyzed for NKA and SP separately using a similar 247 two-way ANOVA with repeated measures. Initial analysis of LH pulse frequencies and amplitudes in the 248 two time bins post-injections indicated no effect of time, so these were analyzed using a simple repeated-249 measures for the 4 hrs post-injection period. Specifically, amplitudes were analyzed by one-way 250 and OVX+ E 2 ewes, with more cell bodies identified in the caudal region of the ARC (range 0-10 cell 258 bodies) compared to middle ( range 0-4 cell bodies) and rostral (range 0-1 cell bodies) regions ( Fig. 1 and  259 2). No SP perikarya were observed in the POA (Fig. 1 and 2B ). On the other hand, fibers immunopositive 260 for SP were observed throughout the entire length of the POA and hypothalamus. In light of the paucity of 261 SP-containing perikarya, it is not surprising that little colocalization of SP and kisspeptin was observed. 262
Specifically, colocalization of these two peptides in ARC cell bodies (see Supplemental Fig. 1 ) was only 263 observed on three occasions (over 2300 kisspeptin cell bodies analyzed from 10 ewes). However, both 264 populations of kisspeptin cells (ARC and POA) and their fibers were surrounded by a plethora of SP 265 immunopositive fibers ( Fig. 2A and 2B) . 266 NK1R-containing cells were observed in the diagonal band of Broca, inner outline of the globus pallidus, 267 anterior hypothalamic area, lateral hypothalamic area, dorsomedial hypothalamus, ventromedial nucleus, 268 ARC and premammillary nucleus (Fig. 1) . Of note, even though NK1R immunopositive cells were 269 numerous throughout the hypothalamus, they were observed more sparsely in the POA (Fig. 2C-2D and 270 Fig. 3C-3D ). Within the ARC, expression of cell bodies was concentrated mainly in the rostral and caudal 271 regions (average 34 cell bodies for each) and less in the middle portion of this nucleus (average 18 cell 272 bodies). Analysis of dual-labeled kisspeptin and NK1R staining revealed infrequent colocalization of these 273 two proteins in the ARC (Fig 2C) . Specifically, only 6.2 ± 3.3% of kisspeptin neurons were seen to contain 274 NK1R, and conversely, only 4.6 ± 1.7% of NK1R containing neurons detected in the ARC also expressed 275 kisspeptin. Similarly to SP, NK1R containing fibers in the ARC where observed in close proximity to 276 kisspeptin cells (Fig. 2C) . 277
Quantitative analysis of sections throughout the POA and MBH, revealed no colocalization of GnRH in SP 278 or NK1R-containing neurons ( Fig. 3 ; over 100 GnRH cell bodies analyzed from 10 ewes, for each set of 279 double-label staining). Similarly, double-labeled fibers were not observed in the ARC or POA. However, 280
GnRH cells and fibers were intimately surrounded by SP and NK1R immunopositive fibers in the 281 mediobasal hypothalamus (Fig. 3 and supplemental Fig. 2) . 282
Experiment 2. Effect of E 2 on SP fiber density and NK1R expression in the ARC. 283
As expected, the presence of E 2 downregulated kisspeptin expression in the rostral, middle and caudal 284 aspects of the ARC (Fig. 4) but had no effect on total GnRH cell numbers (3.9 ± 0.6 and 4.4 ± 1.3 cells in 285 OVX and OVX+ E 2 ewes, respectively). Quantification of SP fiber density did not reveal differences 286 between OVX and OVX+ E 2 ewes (4.23 ± 1.96 and 4.92 ± 1.26 % of analyzed area above the threshold 287 for OVX and OVX+ E 2 ewes, respectively). Similarly, E 2 had no effect on NK1R immunoreactivity in the 288 rostral, middle or caudal aspects of the ARC (Fig. 4) . In the POA, kisspeptin expression was upregulated 289 by E 2 (12.3 ± 4.2 and 38.7 ± 4.2 cells for OVX and OVX+ E 2 ewes, respectively; P<0.02) whereas there 290 was no effect on GnRH expression (18.4 ± 2.7 and 21.4 ± 1.8 cells for OVX and OVX+ E 2 ewes, 291 respectively). No cell bodies immunopositive for SP or NK1R were observed in the vicinity of GnRH 292 neurons in the POA and therefore this area was not included in the analysis. 293
Experiment 3. LH dose-response to NKB in ovary-intact anestrous ewes 294
None of the ewes treated icv with 0 nmoles NKB had an increase in LH concentrations that met the 295 criteria for a response and there was only one animal that responded to 0.05 nmoles NKB, whereas doses 296 of 0.1, 0.2, and 0.5 nmoles NKB produced a response 100% of the time. Based on two-way ANOVA 297
there was a significant effect of time, dose, and dose by treatment interaction; there were no significant 298 differences in pre-injection LH concentrations, but mean LH concentrations during the 2 hrs post-299 injection of either 0.2 or 0.5 nmoles NKB were significantly greater than those following control 300 injections (Fig. 5) . LH pulse frequency was increased (compared to control injections) when animals were 301 injected with 0.1, 0.2, or 0.5 nmoles, but not when they received the lowest does of NKB (Table 2 ). There 302 were no significant differences among groups in LH pulse amplitude, but only data from the three highest 303 doses were analyzed because there were too few pulses in ewes receiving 0 and 0.05 nmoles NKB. In the 304 follow-up study, 0.2 nmoles NKB again induced a response in all five ewes and increased LH from 1.9 ± 305 0.3 ng/ml before injection to 3.1 ± 0.4 ng/ml in the 2 hrs post-injection (P=0.015, paired t-test). Pulse 306 frequencies averaged 1.4 ± 0.2 pulses/2hr and amplitudes were 2.5 ± 0.5 ng/ml after the injection in these 307
animals. 308 309
Experiment 4. What doses of NKA and SP are needed to stimulate LH secretion in ovary-intact 310 anestrous ewes? 311
No ewes responded to icv injection of aCSF with an increase in LH concentrations, although 312 occasional LH pulses occurred either before or 1-3 hrs after injection (Fig 6) . In contrast 80% of the 313 animals responded to icv injections of 2 nmoles of NKA with a robust and prolonged increment in LH, 314 but such a response was only observed in 1 of the 5 animals given 2 nmoles SP icv (Fig. 6, left panels) . 315
Consequently, we next tested 0.5 nmoles NKA and 10 nmoles SP (Fig 6, right panels) . With this lower 316 dose of NKA, one ewe had a robust response immediately following injection of the tachykinin, while 317 three ewes responded to the higher dose of SP, and the other two appeared to have a somewhat delayed 318 increase in episodic LH secretion (Fig 6, right panels) . 319
Statistical analysis of mean LH concentrations indicated there was a dose-response to NKA, with 320 2 nmoles, but not 0.5 nmoles, producing a significant increase in LH concentrations (Fig. 7A) . However, 321 this response was fairly brief as LH returned to pre-injection values during the 2-4 hr period. A similar 322 dose-response in the effects of NKA on LH pulse frequency after injection was seen, but NKA had no 323 significant effects on LH pulse amplitude (Fig. 7B) . 324 SP also produced a significant increase in mean LH concentrations in the first 2 hr period post-325 injection, but this was only seen with the 10 nmole dose of this tachykinin (Fig. 8A) . Although LH 326 values were also higher during the 2-4 hrs after injection of 10 nmoles SP, this was not significant 327 because of increased variability. However, these effects of SP on mean LH concentrations were not 328 reflected in either LH pulse frequency or pulse amplitude as neither parameter was significantly increased 329 at either dose (Fig. 8B ) 330
331
Discussion 332
This is the first detailed description of neurons containing SP and its cognate receptor, NK1R, in the 333 ovine hypothalamus. Although SP was found in hypothalamic areas critical to the control of GnRH and 334 LH secretion, the absence of NK1R in either GnRH-or kisspeptin-containing neurons argues against an 335 important role for this tachykinin in control of reproductive function. The pharmacological data 336 demonstrating that much higher doses of SP and NKA, than of NKB, are needed to stimulate LH 337 secretion also supports this conclusion. 338
Although there has been considerable work describing the expression of SP in the ovine 339 peripheral nervous system and one report of SP-immunoreactive cells in the pars tuberalis of sheep (51), 340 there has been no description of SP-containing neurons in the hypothalamus of this species. We observed 341 that these neurons were largely limited to the ARC, a distribution similar to that reported in humans (52) 342 and monkeys (38,53). In contrast, SP-containing neural cell bodies are found in several other 343 hypothalamic regions in rodents, including the POA, anterior hypothalamic area, and premammillary 344 region (PMR) (12, 54, 55) . It is important to point out, however, that an ICC analysis may not detect all 345 SP-producing neurons. For example, in situ hybridization identified cells containing mRNA for SP in the 346 POA and PMR of humans (56) and there is a similar mismatch between mRNA and protein expression 347 for dynorphin in some regions of the ovine hypothalamus (57). In contrast to the limited distribution of 348 SP-immunoreactive cells, NK1R-expressing cells were observed in several different regions of the ovine 349 diencephalon, with relatively high expression in the lateral POA, the ventromedial nucleus, the caudal 350 ARC, and the PMR. A similar distribution of NK1R has been observed in rats (58) (12). These data raise the possibility of differences among species in 359 expression of SP in kisspeptin neurons. In this regard it is interesting to note that essentially no 360 colocalization of these two peptides was recently observed in tissue from gonadally-intact and castrated 361 male monkeys (38). It is also unlikely that endocrine status can account for these differences as tissue 362 from post-menopausal women, OVX mice, and castrated monkeys were used in these three studies. 363
In light of the accumulating evidence that activation of NK1R signaling stimulates LH secretion 364 in rodents (see Introduction), we hypothesized that NK1R would be found in either GnRH or kisspeptin 365 neurons in the sheep. However, our data do not support this hypothesis: no GnRH neurons or POA 366 kisspeptin neurons contained NK1R, and only 6% of KNDy neurons contained this receptor. In mice, 49 367 % of KNDy neurons, 27% of AVPV/PeN Kiss1 neurons, and 23% of GnRH neurons also contain Tacr1 368 mRNA, based on single cell RT-PCR analysis (12); data on the expression of NK1R in these neurons is 369 not currently available in any other species. It is possible that immunocytochemistry failed to detect 370 NK1R in our study, but the similar anatomy of NK1R-containg neurons in rodents and sheep, and the 371 robust expression of NK1R in ARC neurons not containing kisspeptin argue against this. Moreover, 372 using a similar approach we have observed that the majority of KNDy neurons contain NK3R in sheep 373 (19). Thus these anatomical differences in NK1R expression most likely reflect functional differences in 374 the role of NK1R signaling between these species. Finally, although we did not examine expression of 375 NK2R in this study, previous work found no expression of NK2R in the hypothalamus of rats (48) and no 376 coexpression of this receptor in murine kisspeptin or GnRH neurons (12) . 377
In the second part of this study we determined the minimal dose of NKB, NKA, and SP needed to 378 stimulate LH secretion when given into the third ventricle of ovary-intact anestrous ewes. Ewes were 379 much more sensitive to NKB, with 0.2 nmole producing a consistent increase in LH concentrations, while 380 2.0 nmoles of NKA and 10 nmoles of SP were needed to produce the same effect. A lower dose of NKB 381 (0.1 nmole) consistently produced an initial increase, but mean LH concentrations during the 2 hr post-382 injection was not significantly higher than controls because of its relatively short duration. Thus, the 383 minimal dose of NKB needed to increase LH secretion probably falls between 0.2 and 0.1 nmoles. The 384 minimal effective dose of NKB in this study is lower than that needed to increase bursts of multi-unit 385 electrical activity (MUA) in goats (44), but this may in part be due to differences in the site of 386 administration, since NKB was injected into the lateral ventricle in that study. It is interesting to note that 387 the relative potency of these three tachykinins (NKB>NKA>SP) parallels the relative selectivity of 388 NK3R, not that of NK1R (SP>NKA>NKB) or NK2R (NKA>NKB>SP) (5). This correlation raises the 389 possibility that each of these three tachykinins produces its stimulatory effects on LH secretion in the ewe 390 via NK3R. This possibility is supported by the recent report that a selective NK3R agonist is much more 391 potent at increasing bursts of MUA and LH pulses in OVX goats than selective NK1R or NK2R agonists 392 (61) and by reports that three different selective NK3R antagonists each inhibits episodic LH secretion in 393 OVX ewes (14-16). 394 .
The conclusion that NK3R-signaling is the predominant pathway by which tachykinins control 395 LH secretion in sheep and goats contrasts with recent data in rodents supporting a role for all three 396 tachykinin receptors. This evidence includes reports that: 1) equivalent doses of selective agonists to 397 NK1R, NK2R, and NK3R increase LH secretion in mice (12) and rats (32); 2) NKA and SP can stimulate 398 electrical activity of KNDy neurons in vitro (25); and 3) antagonists to all three tachykinin receptors are 399 required to completely block the stimulatory effects of NKB on the electrical activity of KNDy neurons 400 (25) and episodic LH secretion in OVX rats (34) . Thus there appears to be species differences between 401 rodents and ruminants in the ability of signaling via NK1R or NK2R to stimulate LH secretion. 402
In light of this apparent species difference in redundancy within tachykinin signaling critical for 403 LH secretion, it is of interest to assess the situation in humans and non-human primates. At this time there 404 is no data on colocalization of any tachykinin receptor in GnRH or kisspeptin neurons in these species, 405 but there are a few functional and more extensive genetic studies. In monkeys, the number of SP-406 containing neurons increases following castration (38), but iv administration of SP had no effect on LH 407 secretion (38) and a selective antagonist to NK3R inhibited LH secretion in castrated males and ovary-408 intact females during the follicular phase of the menstrual cycle (16). Thus, most data are consistent with 409 a lack of redundancy in tachykinin signaling in non-human primates. The situation in humans appears to 410 be more complex. Two observations support redundancy: 1) in women, expression of mRNA for SP 411 increases after menopause (6) and 2) in men, iv infusion of SP can stimulate LH secretion (35). On the 412 other hand, the infertility observed in patients with mutations that disrupt NKB-NK3R signaling argues 413 against redundancy (1-3,62,63), although the reversibility of this condition in some individuals (2, 64 ) 414 could be due to signaling via other tachykinin receptors. Finally, the recent report that the selective NK3R 415 antagonist, ESN364, inhibits LH secretion in men and women (17), as it does in sheep and monkeys (16) 416 provides strong evidence that signaling through NK1R or NK2R plays a minor role in the control of LH 417 secretion in humans. This conclusion, if correct, would provide a simple explanation for the differences 418 in the severity of infertility produced by genetic disruption of NKB-NK3R signaling in humans (1-419 3,62,63) and mice (65, 66) . 420
In summary, this study provides the first detailed description of the expression of SP-and NK1R-421 immunoreactivity within the ovine POA and hypothalamus. In contrast to data in humans and mice, but 422 consistent with data in male monkeys, we found little colocalization of SP with kisspeptin. Moreover, the 423 lack of expression in NK1R within GnRH-and kisspeptin-containing neurons and the relatively high 424 doses of NKA and SP needed to stimulate LH secretion in ewes, support the hypothesis that NKB-NK3R 425 signaling is the predominant pathway by which tachykinins control LH secretion in this species. 
